These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11259808)

  • 21. The relation between erythrocyte volume and folate levels is influenced by a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T).
    Lalouschek W; Aull S; Serles W; Wolfsberger M; Deecke L; Pabinger-Fasching I; Mannhalter C
    J Investig Med; 2000 Jan; 48(1):14-20. PubMed ID: 10695265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease.
    Morita H; Taguchi J; Kurihara H; Kitaoka M; Kaneda H; Kurihara Y; Maemura K; Shindo T; Minamino T; Ohno M; Yamaoki K; Ogasawara K; Aizawa T; Suzuki S; Yazaki Y
    Circulation; 1997 Apr; 95(8):2032-6. PubMed ID: 9133512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism.
    Friso S; Girelli D; Trabetti E; Stranieri C; Olivieri O; Tinazzi E; Martinelli N; Faccini G; Pignatti PF; Corrocher R
    Clin Exp Med; 2002 May; 2(1):7-12. PubMed ID: 12049191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
    Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
    Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.
    Klerk M; Verhoef P; Clarke R; Blom HJ; Kok FJ; Schouten EG;
    JAMA; 2002 Oct 23-30; 288(16):2023-31. PubMed ID: 12387655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gene Polymorphism of 5, 10-methylenetetrahydrofolate reductase as a coronary risk factor].
    Morita H; Taguchi J; Kurihara H; Kitaoka M; Kaneda H; Kurihara Y; Maemura K; Shindo T; Minamino T; Ohno M; Yamaoki K; Ogasawara K; Aizawa T; Suzuki S; Yazaki Y
    J Cardiol; 1997 Jun; 29(6):309-15. PubMed ID: 9211089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low plasma folate in combination with the 677 C-->T methylenetetrahydrofolate reductase polymorphism is associated with increased risk of coronary artery disease in Koreans.
    Yoo JH; Park SC
    Thromb Res; 2000 Jan; 97(2):77-84. PubMed ID: 10688336
    [No Abstract]   [Full Text] [Related]  

  • 29. Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting.
    Kosokabe T; Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tomida T; Suzuki T; Kamiya H; Matsui H; Hayakawa T
    Circulation; 2001 Apr; 103(16):2048-54. PubMed ID: 11319193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation of the methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and a new polymorphism in intron 7.
    Hong SH; Song J; Kim JQ
    Mol Cell Probes; 2001 Apr; 15(2):119-23. PubMed ID: 11292330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
    Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
    Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk.
    Lievers KJ; Boers GH; Verhoef P; den Heijer M; Kluijtmans LA; van der Put NM; Trijbels FJ; Blom HJ
    J Mol Med (Berl); 2001 Sep; 79(9):522-8. PubMed ID: 11692165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischemic stroke].
    Huang Y; Zhao Yl Yl; Li S
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):119-22. PubMed ID: 11953142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
    Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations.
    Jee SH; Beaty TH; Suh I; Yoon Y; Appel LJ
    Atherosclerosis; 2000 Nov; 153(1):161-8. PubMed ID: 11058711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age.
    Todesco L; Angst C; Litynski P; Loehrer F; Fowler B; Haefeli WE
    Eur J Clin Invest; 1999 Dec; 29(12):1003-9. PubMed ID: 10583447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: a study in 52 healthy subjects.
    Zittoun J; Tonetti C; Bories D; Pignon JM; Tulliez M
    Metabolism; 1998 Nov; 47(11):1413-8. PubMed ID: 9826223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters.
    Rothenbacher D; Fischer HG; Hoffmeister A; Hoffmann MM; März W; Bode G; Rosenthal J; Koenig W; Brenner H
    Atherosclerosis; 2002 May; 162(1):193-200. PubMed ID: 11947914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.
    Weger M; Stanger O; Deutschmann H; Leitner FJ; Renner W; Schmut O; Semmelrock J; Haas A
    Am J Ophthalmol; 2002 Jul; 134(1):57-61. PubMed ID: 12095808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.